8 Stocks Surging on Big Volume
Sarepta Therapeutics
Sarepta Therapeutics (SRPT) is a biopharmaceutical company focused on the discovery and development of RNA-based therapeutics for the treatment of both rare and infectious diseases. This stock is trading up 16% at $12.53 in recent trading.
Today's Volume: 2.4 million
Average Volume: 888,214 Volume % Change: 325% Shares of SRPT are ripping higher today after ThinkEquity initiated coverage on the stock with a buy rating and a $15 price target. >>5 Stocks Poised for Breakouts From a technical perspective, SRPT is exploding higher here with above average volume, and this stock has entered breakout territory since it's moved above some near-term overhead resistance at $10.78. Traders should now look for long-biased trades as long as SRPT is trending above that breakout level of $10.78 or today's low of $11.65 with strong upside volume flows. I would consider any upside volume day that registers near or above 888,214 shares as bullish. If we continue to see that action, then SRPT has a great chance of hitting $15 in the near future. Cornerstone OnDemandSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
